Exercise Rehabilitation in Patients With Severe Cardiopulmonary Dysfunction on Extracorporeal Life Support
1 other identifier
interventional
40
1 country
1
Brief Summary
Short-term and long-term consequences of severe cardiac and/or lung dysfunction can be increased use of sedation, prolonged bedrest and immobility causing severe loss of muscle mass which could be a risk for muscle weakness, osteoporosis, and lowered endurance. The goal of this study is to show how a structured rehabilitation program can exhibit better short-term and long-term outcomes on patients who are treated with extracorporeal membrane oxygenation (ECMO).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Oct 2024
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2024
CompletedFirst Submitted
Initial submission to the registry
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 24, 2025
January 1, 2025
6 months
January 15, 2025
January 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Timing of exercises
Time spent exercising per each session of rehabilitation program
From enrollment to 3-month follow-up
Secondary Outcomes (8)
Mobility
From enrollment to 3-month follow-up
Mobility
From enrollment to 3-month follow-up
Mobility
From enrollment to 3-month follow-up
Mobility
From enrollment to 3-month follow-up
Mobility
From enrollment to 3-month follow-up
- +3 more secondary outcomes
Other Outcomes (1)
Quality of Life (QOL)
From enrollment to 3-month follow-up
Study Arms (1)
Exercise Group
OTHERThe exercise group will complete the highest intensity exercise and activity as tolerated to maximize their progression of strength, function, and out of bed. This group will also be utlizing the VitalGo Total Lift Bed (TLB) V5 for vertical positioning to provide a better potential for hemodynamic response to activities to include: strength training, mobility tasks, and functional activities like Activities of Daily Living (ADL).
Interventions
Functional Mobility \& ADL's 1. Assisted sitting with progression to unassisted; ADL's 2. Assisted standing with progression to unassisted; ADL's 1. VitalGo bed will be used if unsafe/unable to perform assisted standing. 2. Leg press (VitalGo bed) 3. Ambulation; ADL's
Repetitions will be counted and documented per session per structured exercise.
Eligibility Criteria
You may qualify if:
- Age \>or equal to 18 years old
- On ECMO (VV and/or VA) for cardiopulmonary dysfunction/failure
- Admitted to Lung Recovery Intensive Care Unit (LRICU) or Cardiovascular Intensive Care Unit (CVICU).
- Richmond Agitation and Sedation Scale (RASS) greater than or equal to a score of -2 or greater.
You may not qualify if:
- Hemodynamically unstable as determined by clinical care team (including but not limited to: oxygen saturation \<90%, below target range of mean arterial pressure despite vasoactive or mechanical support, prone positioning, use of mechanical assist device (such as the intra-aortic balloon pump \[IABP\] or ventricular assist device \[VAD\]), active management of intracranial hypertension with abnormal intracranial pressure, spinal precautions, uncontrolled seizures, unstable major fracture, large open surgical wound, known controlled active bleeding).
- Unable to utilize the VitalGo Total Lift BedTM (TLB, Catalog No. V5, Miramar FL) (e.g., height restrictions \[\>228 cm\], weight restrictions \[\>425 lbs\])
- Pregnant or breast feeding.
- Anticipated transfer to another hospital within 72 hours.
- Not anticipated to survive more than 24 hours.
- Unable to obtain informed consent from either patient or legally authorized representative (LAR).
- Patients in the ICU but not on ECMO upon enrollment.
- Patients actively awaiting transplant (heart/lung) without potential for weaning from ECMO.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Healthcare System
San Antonio, Texas, 78229, United States
Related Publications (7)
Kang D, Lim J, Kim BG, Nam H, Kim Y, Kang E, Kim S, Shim S, Lee M, Yoon J, Lee H, Shin SH, Park HY, Cho J. Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases. J Thorac Dis. 2021 Oct;13(10):5752-5764. doi: 10.21037/jtd-21-591.
PMID: 34795924BACKGROUNDFisher CJ, Namas R, Seelman D, Jaafar S, Homer K, Wilhalme H, Young A, Nagaraja V, White ES, Schiopu E, Flaherty K, Khanna D. Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):49-56. Epub 2019 Sep 4.
PMID: 31498073BACKGROUNDEggmann S, Verra ML, Luder G, Takala J, Jakob SM. Effects of early, combined endurance and resistance training in mechanically ventilated, critically ill patients: A randomised controlled trial. PLoS One. 2018 Nov 14;13(11):e0207428. doi: 10.1371/journal.pone.0207428. eCollection 2018.
PMID: 30427933BACKGROUNDHayes K, Holland AE, Pellegrino VA, Young M, Paul E, Hodgson CL. Early rehabilitation during extracorporeal membrane oxygenation has minimal impact on physiological parameters: A pilot randomised controlled trial. Aust Crit Care. 2021 May;34(3):217-225. doi: 10.1016/j.aucc.2020.07.008. Epub 2020 Oct 7.
PMID: 33039302BACKGROUNDHayes K, Holland AE, Pellegrino VA, Mathur S, Hodgson CL. Acute skeletal muscle wasting and relation to physical function in patients requiring extracorporeal membrane oxygenation (ECMO). J Crit Care. 2018 Dec;48:1-8. doi: 10.1016/j.jcrc.2018.08.002. Epub 2018 Aug 7.
PMID: 30118978BACKGROUNDBatycka-Stachnik D, Piwoda A, Darocha T, Spiewak M, Kosinski S, Jarosz A, Hymczak H, Sanak T, Galazkowski R, Piatek J, Konstanty-Kalandyk J, Drwila R. Problems and challenges in the early period of rehabilitating patients with severe hypothermia treated using ecmo support. Wiad Lek. 2016;69(3 pt 2):489-494.
PMID: 27717931BACKGROUNDBellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
PMID: 26903337BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda E Sousse, PhD, MBA
Institute for Extracorporeal Life Support
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Research
Study Record Dates
First Submitted
January 15, 2025
First Posted
January 24, 2025
Study Start
October 25, 2024
Primary Completion
May 1, 2025
Study Completion
December 1, 2025
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share